Clinical safety profile of ticagrelor compared to clopidogrel in 1208 patients: Real world evidence
Introduction: Dual antiplatelet treatment is recommended by current clinical practice guidelines for patients undergoing PCI. The PLATO trial showed superiority of ticagrelor to clopidogrel in reducing the rate of death from vascular causes, myocardial infarction and stroke without increase in the r...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2018-12-01
|
| Series: | The Egyptian Heart Journal |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1110260818300553 |